Dr. Reddy’s launches generic Lamictal ODT

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Monday announced the U.S. launch of its generic of Lamictal (lamotrigine) ODT orally disintegrating tablets. 

 

The Dr. Reddy’s generic will be available in 25-, 50-, 100- and 200-mg dosage strengths in 30-count bottles. The drug had U.S. sales of $65.5 million for the 12 months ending July 2016, according to IMS Health.